[Chrysin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis in rats]. 2023

Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
School of Chinese Materia Medica,Beijing University of Chinese Medicine Beijing 100029,China.

The purpose of this study is to investigate whether chrysin reduces cerebral ischemia-reperfusion injury(CIRI) by inhi-biting ferroptosis in rats. Male SD rats were randomly divided into a sham group, a model group, high-, medium-, and low-dose chrysin groups(200, 100, and 50 mg·kg~(-1)), and a positive drug group(Ginaton, 21.6 mg·kg~(-1)). The CIRI model was induced in rats by transient middle cerebral artery occlusion(tMCAO). The indexes were evaluated and the samples were taken 24 h after the operation. The neurological deficit score was used to detect neurological function. The 2,3,5-triphenyl tetrazolium chloride(TTC) staining was used to detect the cerebral infarction area. Hematoxylin-eosin(HE) staining and Nissl staining were used to observe the morphological structure of brain tissues. Prussian blue staining was used to observe the iron accumulation in the brain. Total iron, lipid pero-xide, and malondialdehyde in serum and brain tissues were detected by biochemical reagents. Real-time quantitative polymerase chain reaction(RT-qPCR), immunohistochemistry, and Western blot were used to detect mRNA and protein expression of solute carrier fa-mily 7 member 11(SLC7A11), transferrin receptor 1(TFR1), glutathione peroxidase 4(GPX4), acyl-CoA synthetase long chain family member 4(ACSL4), and prostaglandin-endoperoxide synthase 2(PTGS2) in brain tissues. Compared with the model group, the groups with drug intervention showed restored neurological function, decreased cerebral infarction rate, and alleviated pathological changes. The low-dose chrysin group was selected as the optimal dosing group. Compared with the model group, the chrysin groups showed reduced content of total iron, lipid peroxide, and malondialdehyde in brain tissues and serum, increased mRNA and protein expression levels of SLC7A11 and GPX4, and decreased mRNA and protein expression levels of TFR1, PTGS2, and ACSL4. Chrysin may regulate iron metabolism via regulating the related targets of ferroptosis and inhibit neuronal ferroptosis induced by CIRI.

UI MeSH Term Description Entries
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D002544 Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction). Anterior Choroidal Artery Infarction,Cerebral Infarct,Infarction, Cerebral,Posterior Choroidal Artery Infarction,Subcortical Infarction,Cerebral Infarction, Left Hemisphere,Cerebral Infarction, Right Hemisphere,Cerebral, Left Hemisphere, Infarction,Cerebral, Right Hemisphere, Infarction,Infarction, Cerebral, Left Hemisphere,Infarction, Cerebral, Right Hemisphere,Infarction, Left Hemisphere, Cerebral,Infarction, Right Hemisphere, Cerebral,Left Hemisphere, Cerebral Infarction,Left Hemisphere, Infarction, Cerebral,Right Hemisphere, Cerebral Infarction,Right Hemisphere, Infarction, Cerebral,Cerebral Infarctions,Cerebral Infarcts,Infarct, Cerebral,Infarction, Subcortical,Infarctions, Cerebral,Infarctions, Subcortical,Infarcts, Cerebral,Subcortical Infarctions
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D000079403 Ferroptosis A form of REGULATED CELL DEATH initiated by oxidative perturbations of the intracellular microenvironment that is under constitutive control by glutathione peroxidase 4 and can be inhibited by iron chelators and lipophilic antioxidants. Oxytosis
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
May 2024, Heliyon,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
May 2023, Antioxidants (Basel, Switzerland),
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
January 2024, Journal of vascular research,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
October 2020, Journal of biological regulators and homeostatic agents,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
February 2023, Brain research bulletin,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
March 2023, International immunopharmacology,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
October 2023, Transplantation,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
November 2023, Biological & pharmaceutical bulletin,
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
March 2021, Anatomical record (Hoboken, N.J. : 2007),
Jin-Feng Shang, and Jia-Kang Jiao, and Qian-Nan Li, and Ying-Hui Lu, and Jing-Yi Wang, and Ming-Xue Yan, and Yin-Lian Wen, and Gui-Jin-Feng Huang, and Xiao-Lu Zhang, and Xin Liu
March 2019, Frontiers in bioscience (Landmark edition),
Copied contents to your clipboard!